At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Observational study - sample collection only. (other)
- How long the study runs
- Study runs about 175 months (dates as stated)
- About the drug or intervention
- Observational study - sample collection only. — other: No intervention - blood and/or bone marrow sample collection only
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 250
- Started
- 2020-07-22
- Last checked
- 2023-08
Plain English Summary
What is this study?
- • Testing a new treatment for multiple myeloma
- • Clinical study - 250 participants
- • Myeloma is a bone marrow cancer with over 5000 patients diagnosed in the UK each year
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with multiple myeloma
Where?
- • Sutton - The Royal Marsden NHS Foundation Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Myeloma is a bone marrow cancer with over 5000 patients diagnosed in the UK each year. Researchers are committed to improving understanding of myeloma and developing more effective treatments with fewer side effects in order to improve patient outcomes. In order to do this, researchers are collecting samples of blood and bone marrow to test the activity of potential new treatments in the laboratory and to understand what may be the cause of some treatments not working.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Participants who have a diagnosis, or suspected diagnosis, of myeloma or related plasma cell disorder
- ✓Participants who are undergoing a peripheral blood or bone marrow aspirate sampling for diagnostic, staging or...
- ✓Participants aged 18 years of age or above
- ✓Participants willing to consent to an additional sample being taken at the time of their peripheral blood or bone...
Who cannot take part
- ✗Participants unable to provide consent
- ✗Participants with known active infectious diseases (e.g. HIV, Hepatitis B/C, COVID) that pose a risk to the use of...
See the full criteria
Where Is This Study? (1 UK site)
The Royal Marsden NHS Foundation Trust
Sutton SM25PT, United Kingdom
How to Get in Touch
Disco Team
Sponsor contactCONTACT